You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for New Drug Application (NDA): 050616


✉ Email this page to a colleague

« Back to Dashboard


NDA 050616 describes TOBRADEX, which is a drug marketed by Novartis, Sandoz, and Harrow Eye, and is included in three NDAs. It is available from six suppliers. There are three patents protecting this drug. Additional details are available on the TOBRADEX profile page.

The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.
Summary for 050616
Tradename:TOBRADEX
Applicant:Novartis
Ingredient:dexamethasone; tobramycin
Patents:0
Pharmacology for NDA: 050616
Suppliers and Packaging for NDA: 050616
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBRADEX dexamethasone; tobramycin OINTMENT;OPHTHALMIC 050616 NDA Novartis Pharmaceuticals Corporation 0078-0876 0078-0876-01 3.5 g in 1 TUBE (0078-0876-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;OPHTHALMICStrength0.1%;0.3%
Approval Date:Sep 28, 1988TE:RLD:Yes

Expired US Patents for NDA 050616

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis TOBRADEX dexamethasone; tobramycin OINTMENT;OPHTHALMIC 050616-001 Sep 28, 1988 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.